COST
50
-3
CVS
58
6
KSS
59
5
MRO
42
-5
FLS
63
-6
HOG
56
4
WBA
27
8
YUM
56
4
CNX
83
4
GE
81
2
LLY
42
-5
TEL
68
2
CVX
40
8
EOG
47
9
AON
56
4
ADM
30
2
WMB
62
2
RRC
59
3
SIG
64
3
TXT
60
4
COST
50
-3
CVS
58
6
KSS
59
5
MRO
42
-5
FLS
63
-6
HOG
56
4
WBA
27
8
YUM
56
4
CNX
83
4
GE
81
2
LLY
42
-5
TEL
68
2
CVX
40
8
EOG
47
9
AON
56
4
ADM
30
2
WMB
62
2
RRC
59
3
SIG
64
3
TXT
60
4
Financhill
Back

XTL Biopharmaceuticals Vs. Can Fite Biofarma Industry Stock Comparison

Sell
44

XTLB
XTL Biopharmaceuticals

Last Price:
2.53
Seasonality Move:
-7.87%
Sell
42

CANF
Can Fite Biofarma

Last Price:
2.02
Seasonality Move:
0.68%
Sell
44
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy, Sell or Hold?

  • The current XTL Biopharmaceuticals [XTLB] share price is $2.56. The Score for XTLB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • XTLB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $2.02. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTLB Stock Price Chart

What is XTL Biopharmaceuticals's stock price today?

  • The XTL Biopharmaceuticals share price today is $2.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $2.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

XTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 48.96 Sell
Chaikin Money Flow: 1319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.48 - 2.7) Sell
Bollinger Bands (100): (2.34 - 2.76) Buy

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 36.28 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.08 - 2.36) Sell
Bollinger Bands (100): (2.11 - 3.15) Sell

XTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.48 Buy
20-day SMA: 2.58 Sell
50-day SMA: 2.66 Sell
200-day SMA: 2.03 Buy
8-day EMA: 2.52 Buy
20-day EMA: 2.56 Buy
50-day EMA: 2.58 Sell
200-day EMA: 2.17 Buy

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.04 Sell
20-day SMA: 2.2 Sell
50-day SMA: 2.59 Sell
200-day SMA: 2.36 Sell
8-day EMA: 2.07 Sell
20-day EMA: 2.19 Sell
50-day EMA: 2.41 Sell
200-day EMA: 2.56 Sell

XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

XTL Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):